정부/공공기관
임상시험센터
CRO
분석CRO/센트럴랩
유관기관/협회
정보서비스
해외 유관 기관
* CRO 게재 기준: CRO자율등록 기관
ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2550건이 검색되었습니다.
| No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 100 | Recruiting | Treatments for COVID-19: Canadian Arm of the SOLIDARITY Trial | COVID-19 | Drug: Interferon beta-1a Drug: Remdesivir |
Phase 2 | Sunnybrook Health Sciences Centre, AbbVie, Apotex Inc. | OTHER | 2900 | All | 18 Years | Peter Lougheed Centre, Calgary, Alberta, Canada Foothills Medical Centre, Calgary, Alberta, Canada Rockyview General Hospital, Calgary, Alberta, Canada South Health Campus, Calgary, Alberta, Canada Royal Alexandra Hospital, Edmonton, Alberta, Canada Misericordia Community Hospital, Edmonton, Alberta, Canada University of Alberta Hopsital, Edmonton, Alberta, Canada Grey Nuns Community Hospital, Edmonton, Alberta, Canada Interior Health Royal Inland Hospital, Kamloops, British Columbia, Canada Lions Gate Hospital, North Vancouver, British Columbia, Canada Richmond Hospital, Richmond, British Columbia, Canada Vancouver General Hospital, Vancouver Coastal Health, Univeristy of British Columbia, Vancouver, British Columbia, Canada St Paul's Hospital, Vancouver, British Columbia, Canada Island Health - Royal Jubilee Hospital, Victoria, British Columbia, Canada Island Health - Victoria General Hospital, Victoria, British Columbia, Canada Island Health - Nanaimo Regional General Hospital, Victoria, British Columbia, Canada St. Boniface Hospital, Winnipeg, Manitoba, Canada Health Sciences Centre, Winnipeg, Manitoba, Canada Grace General Hospital, Winnipeg, Manitoba, Canada Eastern Regional Health Authority, Saint John's, Newfoundland and Labrador, Canada Nova Scotia Health Authority, Halifax, Nova Scotia, Canada Royal Victoria Regional Health Centre, Barrie, Ontario, Canada William Osler Health System - Brampton Civic Hospital, Brampton, Ontario, Canada William Osler Health System - Etobicoke General Hospital, Etobicoke, Ontario, Canada St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada Grand River Hospital, Kitchener, Ontario, Canada St. Mary's General Hospital, Kitchener, Ontario, Canada St.Joseph's Health Care, London, Ontario, Canada University Hospital, London, Ontario, Canada Victoria Hospital, London, Ontario, Canada Markham Stouffville Hospital, Markham, Ontario, Canada Trillium Health Partners -Mississauga Site, Mississauga, Ontario, Canada Trillium Health Partners-Credit Valley Hospital, Mississauga, Ontario, Canada The Ottawa Hospital - General Campus, Ottawa, Ontario, Canada Hopital Montfort, Ottawa, Ontario, Canada The Ottawa Hospital - Civic Campus, Ottawa, Ontario, Canada Queensway Carleton Hospital, Ottawa, Ontario, Canada Niagara Health, Saint Catharines, Ontario, Canada Scarborough Health Network - Centenary Hospital, Scarborough, Ontario, Canada Scarborough Health Network - General Hospital, Scarborough, Ontario, Canada Scarborough Health Network - Birchmount Hospital, Scarborough, Ontario, Canada Thunder Bay Regional Health Sciences Centre, Thunder Bay, Ontario, Canada North York General Hospital, Toronto, Ontario, Canada Humber River Hospital, Toronto, Ontario, Canada Michael Garron Hospital, Toronto, Ontario, Canada Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada St. Michael's Hospital, Toronto, Ontario, Canada Mount Sinai Hospital, Toronto, Ontario, Canada Toronto Western Hospital, Toronto, Ontario, Canada Unity Health Toronto - St. Joseph's Health Centre, Toronto, Ontario, Canada CISSS de la Monteregie Centre, Greenfield Park, Quebec, Canada Centre Hospitalier de l'Universite de Montreal (CHUM), Montreal, Quebec, Canada McGill University Health Centre-Glen Site Royal Victoria Hospital, Montreal, Quebec, Canada CHU de Quebec - Universite Laval, Quebec, Quebec, Canada Institut Universitaire de Cardiologie et de Pneumologie de Quebec- Universite Laval, Quebec, Quebec, Canada Centre Integre Universitaire de Sante et de Services Sociaux de l'Estrie - Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Quebec, Canada Royal University Hospital, Saskatoon, Saskatchewan, Canada |
| 99 | Recruiting | Tregs for the Treatment of Acute Respiratory Distress Syndrome (ARDS) Associated With COVID-19 (regARDS) | Acute Respiratory Distress Syndrome Due to Disease Caused by 2019-nCoV | Biological: Cryopreserved Ex Vivo Expanded Polyclonal CD4+CD127lo/-CD25+ T Regulatory Cells | Phase 1 | Jeffrey Bluestone, National Institute of Allergy and Infectious Diseases (NIAID), Immune Tolerance Network (ITN) | OTHER | 18 | All | 18 Years ~ 70 Years | University of North Carolina, Chapel Hill, North Carolina, United States The Ohio State University, Columbus, Ohio, United States |
| 98 | Not yet recruiting | Trial Evaluating Efficacy and Safety of Anticoagulation in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort | COVID19 Pneumonia | Drug: Tinzaparin or unfractionated heparin | Phase 2 | Assistance Publique - Hopitaux de Paris | OTHER | 808 | All | 18 Years | Reanimation hopital Louis Mourier, Colombes, Hauts De Seine, France reanimation hopital Cochin, Paris, France Medecine vasculaire, Hopital Europeen Georges Pompidou, Paris, France |
| 97 | Not yet recruiting | Trial Evaluating Efficacy and Safety of Bevacizumab (Avastin®/Zeribev®) in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort | COVID19 Pneumonia | Drug: Bevacizumab Injection | Phase 2 | Assistance Publique - Hopitaux de Paris | OTHER | 130 | All | 18 Years | |
| 96 | Not yet recruiting | Trial Evaluating Efficacy and Safety of Nivolumab (Optivo®) in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort. | COVID19- Infection With SARS-CoV-2 Virus | Drug: Nivolumab Injection | Phase 2 | Assistance Publique - Hopitaux de Paris | OTHER | 92 | All | 18 Years | Pneumologie hopital Tenon, Paris, France |
| 95 | Completed | Trial Evaluating the Efficacy of Local Budesonide Therapy in the Management of Hyposmia in COVID-19 Patients Without Signs of Severity | Anosmia | Drug: Budesonide Nasal Other: Physiological serum |
Phase 3 | Fondation Ophtalmologique Adolphe de Rothschild, Hopital Lariboisiere | NETWORK | 120 | All | 18 Years | Amelie YAvchitz, Paris, France |
| 94 | Recruiting | Trial of Alpha One Antitrypsin Inhalation in Treating Patient With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) | Coronavirus | Drug: alpha one antitrypsin inhalation | Early Phase 1 | Ministry of Health, Saudi Arabia | OTHER_GOV | 150 | All | 18 Years | Ministry of Health, Mecca, Saudi Arabia |
